## Background: African-american patients have been under-represented in oncology clinical trials. better understanding barriers to african-american participation may help increase the accrual of african-american patients onto clinical trials. ## Methods: Two hundred eighteen patients with maligna
β¦ LIBER β¦
Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants' experiences
β Scribed by Karen Cox
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 72 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1057-9249
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Barriers to the participation of African
β
Anjali S. Advani; Benjamin Atkeson; Carrie L. Brown; Bercedis L. Peterson; Laura
π
Article
π
2003
π
John Wiley and Sons
π
English
β 94 KB
π 2 views
Histiocytosis X: Clinical trial of chlor
β
Lahey, M. E. ;Heyn, R. M. ;Newton, W. A. ;Shore, N. ;Smith, W. B. ;Leikin, S. ;H
π
Article
π
1979
π
John Wiley and Sons
π
English
β 366 KB
## Abstract A prospective study for histiocytosis X was designed to determine whether βgood riskβ patients, ie, those without evidence of dysfunction of liver, lung, or hemopoietic system, would respond to single agent therapy; in this case chlorambucil (CMB) used in a dose of 5 mgm/m^2^ /day. If t
Phase 2 trial of primary systemic therap
β
Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E
π
Article
π
2010
π
John Wiley and Sons
π
English
β 199 KB
π 2 views